MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Bradykinesia"

  • 2018 International Congress

    Assessment of Motor Symptoms in Parkinson’s disease using Flexible Wearable Sensors and Deep Neural Networks: A CIS-PD substudy

    L. Lonini, A. Dai, C. Poon, N. Shawen, L. Shimanovich, T. Simuni, D. Daeschler, J. Rogers, A. Jayaraman (Chicago, IL, USA)

    Objective: To develop an algorithm to characterize in-office motor symptoms of Parkinson’s disease (PD) using multiple wireless sensors, and to compare symptom recognition in activities…
  • 2018 International Congress

    Liquid sinemet in the management of complex motor fluctuations in advanced Parkinson’s Disease

    C. Sung, M. Danoudis, R. Iansek (Melbourne, Australia)

    Objective: To investigate the effectiveness of Levodopa carbidopa ascorbic acid solution (LCAS) in reducing the severity of bradykinesia and dyskinesia in advanced Parkinson’s disease (PD).…
  • 2018 International Congress

    Objective Data in Parkinson’s Disease: A description of over 20,000 Parkinson’s symptom scores across the world using the Personal KinetiGraph (PKG)

    P. Lynch, R. Pahwa, F. Bergquist, M. Horne (Minnetonka, MN, USA)

    Objective: The objective of this population study was to update & expand upon previous research [8] done to describe the objective symptom scores from a…
  • 2018 International Congress

    Quantitative assessment of the effectiveness of adaptive Deep Brain Stimulation in Parkinson’s disease

    D. Piña-Fuentes, M. Tijssen, M. Oterdoom, S. Little, J. van Zijl, T. van Laar, P. Brown, M. van Dijk, M. Beudel (Groningen, Netherlands)

    Objective: To determine the effectiveness of Adaptive Deep Brain Stimulation (aDBS) in PD patients compared to cDBS and non-medicated PD patients (OFF). Background: aDBS based…
  • 2018 International Congress

    Bradykinesia assessment using evolutionary algorithms in Parkinson’s disease: Clinical validation

    C. Gao, S. Smith, M. Lones, S. Jamieson, J. Alty, J. Cosgrove, P. Zhang, J. Liu, Y. Chen, J. Du, S. Cui, H. Zhou, S. Chen (Shanghai, China)

    Objective: The aim of this study was to a) validate the ability of the evolutionary algorithms to distinguish PD patients in the early stage of…
  • 2018 International Congress

    Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry

    D. Johansson, A. Ericsson, A. Johansson, A. Medvedev, D. Nyholm, F. Ohlsson, M. Senek, J. Spira, I. Thomas, J. Westin, F. Bergquist (Gothenburg, Sweden)

    Objective: This four-week open-label observational study describes the effect of introducing a microtablet dose dispenser and adjusting doses based on objective free-living motor symptom monitoring…
  • 2018 International Congress

    Quantitative Assessment of Appendicular Bradykinesia in Parkinson’s Disease using Wearable Sensors

    A. Dowling, M. Brys, J. Paskavitz, V. Auclair, D. McLaren, R. Postuma, B. Bedell, M. Cedarbaum (Cambridge, MA, USA)

    Objective: To quantify appendicular bradykinesia during a repetitive motor task in patients with Parkinson’s disease. Background: Bradykinesia is a cardinal motor symptom of Parkinson’s Disease…
  • 2018 International Congress

    Does altering medication to avoid dyskinesia positively alters the breadth of the motor repertoire of patients with Parkinson’s disease? A pilot study

    S. Bogard, E. Goubault, K. Lebel, C. Duval (Montreal, QC, Canada)

    Objective: The aim of this study was to assess the level of drug-induced dyskinesia (DID), the presence of other motor symptoms of PD, and the…
  • 2018 International Congress

    Evaluating the clinical utility of the Parkinson’s KinetiGraph (PKG™) in the remote management of Parkinson’s disease

    T. Dominey, L. Hutchinson, E. Pearson, F. Murphy, L. Bell, C. Carroll (Plymouth, United Kingdom)

    Objective: To evaluate the clinical utility of the Parkinson’s Kinetigraph (PKG™) in the remote management of Parkinson’s disease (PD) in terms of assistance with therapeutic…
  • 2018 International Congress

    West Sweden Parkinson Objective Measurement Registry Study (WestPORTS)

    F. Bergquist, A. Ax, A. Sjostrom, S. Wallerstedt (Gothenburg, Sweden)

    Objective: To study a population representative Parkinson’s Disease (PD) patient cohort characterized with objective 6x24h home measurements using the Parkinson Kinetigraph (PKG, Global Kinetics). To…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley